广发纳斯达克生物科技美元(001093)
动态评分： 5.90分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | UTHR | 联合治疗 | 237.66 | 1.37% |
| 2024-12-31 | VTRS | Viatris Inc | 224.29 | 1.29% |
| 2024-12-31 | SNY | 赛诺菲 | 219.18 | 1.26% |
| 2024-12-31 | NBIX | 神经分泌生物科学 | 208.61 | 1.2% |
| 2024-12-31 | INCY | 因塞特医疗 | 200.84 | 1.16% |
| 2024-12-31 | SMMT | Summit Therapeutics Inc | 198.62 | 1.14% |
| 2024-12-31 | BMRN | 拜玛林制药 | 189.09 | 1.09% |
| 2024-12-31 | INSM | Insmed Inc | 186.41 | 1.07% |
| 2024-12-31 | SRPT | Sarepta Therapeutics Inc | 175.33 | 1.01% |
| 2024-12-31 | RPRX | Royalty Pharma plc-A | 171.07 | 0.98% |
| 2024-12-31 | BNTX | BioNTech SE ADR | 168.82 | 0.97% |
| 2024-12-31 | MEDP | Medpace Holdings Inc | 155.95 | 0.9% |
| 2024-12-31 | PCVX | Vaxcyte Inc | 154 | 0.89% |
| 2024-12-31 | EXEL | 伊克力西斯 | 143.53 | 0.83% |
| 2024-12-31 | ITCI | Intra-Cellular Therapies Inc | 133.64 | 0.77% |
| 2024-12-31 | ROIV | Roivant Sciences Ltd | 129.98 | 0.75% |
| 2024-12-31 | ASND | Ascendis Pharma AS ADR | 125.29 | 0.72% |
| 2024-12-31 | ONC | 百济神州 | 123.62 | 0.71% |
| 2024-12-31 | JAZZ | 爵士制药 | 112.34 | 0.65% |
| 2024-12-31 | RVMD | Revolution Medicines Inc | 111.05 | 0.64% |
公告&资料
